Quest Diagnostics Incorporated (FRA:QDI)

Germany flag Germany · Delayed Price · Currency is EUR
158.90
-5.20 (-3.17%)
Last updated: Oct 21, 2025, 4:04 PM CET
-3.17%
Market Cap17.69B
Revenue (ttm)9.25B
Net Income (ttm)820.76M
Shares Outn/a
EPS (ttm)7.26
PE Ratio21.55
Forward PE18.05
Dividend2.83 (1.77%)
Ex-Dividend DateOct 3, 2025
Volume40
Average Volume22
Open163.05
Previous Close164.10
Day's Range158.90 - 168.55
52-Week Range135.85 - 168.15
Betan/a
RSI53.59
Earnings DateOct 21, 2025

About Quest Diagnostics

Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans,... [Read more]

Industry Medical Laboratories
Founded 1967
Employees 56,000
Stock Exchange Frankfurt Stock Exchange
Ticker Symbol QDI
Full Company Profile

Financial Performance

In 2024, Quest Diagnostics's revenue was $9.87 billion, an increase of 6.70% compared to the previous year's $9.25 billion. Earnings were $866.00 million, an increase of 1.88%.

Financial numbers in USD Financial Statements

News

There is no news available yet.